DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "DrugPatentWatch" database table to their offering.
Customer segments are: US healthcare payers (Job Title: Director, P&T; and other roles related to pharmacy and formulary) consulting firms, branded and generic pharma and law firms.
Clients include: McKesson, US Department of Justice, US Army, Fish & Richardson, Fuji Chemical, Harvard Business School, McKinsey, Johnson & Johnson, Merck, Teva, UBS, and QuintilesIMS.
The database includes global patent data (130+ countries) and an optional add-on of expired patents - Enterprisewide Price includes Expired Patents.
Deep Knowledge on Small-Molecule Drugs on a Daily Basis
- Portfolio Management
- PBM/Formulary and pharmacy & therapeutics (P&T)
- Anticipate future budget requirements and proactively identify generic sources
- Specialty pharmaceuticals and generics
- Identify market entry opportunities and inform portfolio management decisions
Business Intelligence
- Branded pharmaceutical manufacturers
- - Assess past successes of patent challengers and elucidate research paths of competitors
- Buyers, wholesalers, and distributors
- - Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs
- API manufacturers
- - Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers
Email Alerts
- Set up watchlists for daily email updates
- Comprehensive Global Coverage
- Drug patents in dozens of countries
- European Supplementary Protection Certificates
Take your data with you
- Export data to Excel or CSV
- Global Patent Coverage
- Patent coverage in 130+ countries
- Supplementary Protection Certificates
- Intuitive Interface
- Quickly filter and sort results
Pharmaceutical Business Intelligence
- Anticipate P&T budget requirements
- Evaluate market entry opportunities
- Find generic sources and suppliers
- Predict branded drug patent expiration
Thousands of drugs from more than 1,000 branded and generic firms:
- 828 Pharmaceutical Classes
- 6,623 Drugs Profiled
- 1,842 Branded and Generic Firms
- 114,390 Global Patents
- 133 Countries
For more information about this database table visit http://www.researchandmarkets.com/research/z3lg59/drugpatentwatch
